Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 697183, 6 pages
http://dx.doi.org/10.1155/2012/697183
Research Article

Antibacterial Activity of Rhodomyrtus tomentosa (Aiton) Hassk. Leaf Extract against Clinical Isolates of Streptococcus pyogenes

1Faculty of Traditional Thai Medicine and Natural Products Research Center, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand
2Department of Bio- and Chemical Engineering, Technical University of Dortmund, Technical Biochemistry, Emil-Figge-Strasse 66-68, 44227 Dortmund, Germany
3Department of Microbiology and Natural Products Research Center, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla 90112, Thailand

Received 3 May 2012; Revised 26 July 2012; Accepted 31 July 2012

Academic Editor: Jenny M. Wilkinson

Copyright © 2012 Surasak Limsuwan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. W. Cunningham, “Pathogenesis of group a streptococcal infections,” Clinical Microbiology Reviews, vol. 13, no. 3, pp. 470–511, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. Bisno, M. A. Gerber, J. M. Gwaltney, E. L. Kaplan, and R. H. Schwartz, “Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis,” Clinical Infectious Diseases, vol. 35, no. 2, pp. 113–125, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Pichichero, J. R. Casey, T. Mayes et al., “Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies,” Pediatric Infectious Disease Journal, vol. 19, no. 9, pp. 917–923, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. A. S. Gastanaduy, B. B. Huwe, and E. L. Kaplan, “Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis,” The Lancet, vol. 2, no. 8193, pp. 498–502, 1980. View at Google Scholar · View at Scopus
  5. T. D. Smith, W. C. Huskins, K. S. Kim, and E. L. Kaplan, “Efficacy of β-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis,” The Journal of Pediatrics, vol. 110, no. 5, pp. 777–782, 1987. View at Google Scholar · View at Scopus
  6. A. Stromberg, A. Schwan, and O. Cars, “Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil,” Scandinavian Journal of Infectious Diseases, vol. 20, no. 1, pp. 37–46, 1988. View at Google Scholar · View at Scopus
  7. K. Roos and P. Larsson, “Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis,” Scandinavian Journal of Infectious Diseases, vol. 29, no. 2, pp. 141–145, 1997. View at Google Scholar · View at Scopus
  8. E. L. Kaplan and D. R. Johnson, “Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis,” Pediatrics, vol. 108, no. 5, pp. 1180–1186, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Baker, I. Behlau, and M. R. Tierney, “Infections of the pharynx, larynx, epiglottis, trachea, and thyroid,” in Infectious Diseases., S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow, Eds., pp. 540–548, W. B. Saunders Company, Philadelphia, Pa, USA, 1998. View at Google Scholar
  10. G. E. Stein, S. Christensen, and N. Mummaw, “Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitis,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 10, no. 11, pp. 949–953, 1991. View at Google Scholar · View at Scopus
  11. D. Adam, H. Scholz, C. Aspe et al., “Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 15, no. 9, pp. 712–717, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Feng and X. Shen, “PP-011 High level macrolide resistant Streptococcus pyogenes Isolated from Chinese children and the relationship with Tn6002,” International Journal of Infectious Diseases, vol. 13, supplement 1, p. S53, 2009. View at Publisher · View at Google Scholar
  13. M. Gracia, C. Díaz, P. Coronel et al., “Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program,” Diagnostic Microbiology and Infectious Disease, vol. 64, no. 1, pp. 52–56, 2009. View at Google Scholar · View at Scopus
  14. A. G. Michos, C. G. Bakoula, M. Braoudaki et al., “Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types,” Diagnostic Microbiology and Infectious Disease, vol. 64, no. 3, pp. 295–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Malli, E. Tatsidou, A. Damani et al., “Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification,” International Journal of Antimicrobial Agents, vol. 35, no. 6, pp. 614–615, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Bauer, M. M. Georgousakis, T. Vu et al., “Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein,” Vaccine, vol. 12, no. 12, pp. 2197–2205, 2012. View at Google Scholar
  17. M. Zaman, A. B. Abdel-Aal, and Y. Fujita, “Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship,” PLoS ONE, vol. 7, no. 1, Article ID e30146, 2012. View at Google Scholar
  18. S. Limsuwan, E. N. Trip, T. R. H. M. Kouwen et al., “Rhodomyrtone: a new candidate as natural antibacterial drug from Rhodomyrtus tomentosa,” Phytomedicine, vol. 16, no. 6-7, pp. 645–651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Hiranrat and W. Mahabusarakam, “New acylphloroglucinols from the leaves of Rhodomyrtus tomentosa,” Tetrahedron, vol. 64, no. 49, pp. 11193–11197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. B. A. Forbes, D. F. Sahm, and A. S. Weissfeld, Bailey & Scott’s Diagnostic Microbiology, Mosby, St. Louis, Mo, USA, 2002.
  21. CLSI: Clinical and Laboratory Standards Institute, “Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard,” in Clinical and Laboratory Standards Institute Document M07-A8, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 8th edition, 2009. View at Google Scholar
  22. S. Chusri and S. P. Voravuthikunchai, “Quercus infectoria: a candidate for the control of methicillin-resistant Staphylococcus aureus infections,” Phytotherapy Research, vol. 22, no. 4, pp. 560–562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. C. F. Carson, B. J. Mee, and T. V. Riley, “Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 6, pp. 1914–1920, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Suwalak and S. P. Voravuthikunchai, “Morphological and ultrastructural changes in the cell structure of enterohaemorrhagic Escherichia coli O157:H7 following treatment with Quercus infectoria nut galls,” Journal of Electron Microscopy, vol. 58, no. 5, pp. 315–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. E. Pichichero and J. R. Casey, “Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis,” Otolaryngology, vol. 137, no. 6, pp. 851–857, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Limsuwan, S. Subhadhirasakul, and S. P. Voravuthikunchai, “Medicinal plants with significant activity against important pathogenic bacteria,” Pharmaceutical Biology, vol. 47, no. 8, pp. 683–689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Horne, M. Holm, C. Oberg, S. Chao, and D. G. Young, “Antimicrobial effects of essential oils on Streptococcus pneumoniae,” Journal of Essential Oil Research, vol. 13, no. 5, pp. 387–392, 2001. View at Google Scholar · View at Scopus
  28. J. Oonmetta-aree, T. Suzuki, P. Gasaluck, and G. Eumkeb, “Antimicrobial properties and action of galangal (Alpinia galanga Linn.) on Staphylococcus aureus,” LWT-Food Science and Technology, vol. 39, no. 10, pp. 1214–1220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. W. B. Hugo and A. R. Longworth, “Some aspects of the mode of action of chlorhexidine,” The Journal of Pharmacy and Pharmacology, vol. 16, no. 10, pp. 655–662, 1964. View at Google Scholar · View at Scopus
  30. H. L. Joswick, T. R. Corner, J. N. Silvernale, and P. Gerhardt, “Antimicrobial actions of hexachlorophene: release of cytoplasmic materials,” Journal of Bacteriology, vol. 108, no. 1, pp. 492–500, 1971. View at Google Scholar · View at Scopus
  31. S. Silver and L. Wendt, “Mechanism of action of phenethyl alcohol: breakdown of the cellular permeability barrier,” Journal of Bacteriology, vol. 93, no. 2, pp. 560–566, 1967. View at Google Scholar · View at Scopus
  32. G. O. Onawunmi, “In vitro studies on the antibacterial activity of phenoxyethanol in combination with lemon grass oil,” Pharmazie, vol. 43, no. 1, pp. 42–44, 1988. View at Google Scholar · View at Scopus
  33. B. O. T. Ifesan, N. Joycharat, and S. P. Voravuthikunchai, “The mode of antistaphylococcal action of Eleutherine americana,” FEMS Immunology and Medical Microbiology, vol. 57, no. 2, pp. 193–201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Saising, A. Hiranrat, W. Mahabusarakam, M. Ongsakul, and S. P. Voravuthikunchai, “Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a natural antibiotic for staphylococcal cutaneous infections,” Journal of Health Science, vol. 54, no. 5, pp. 589–595, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Limsuwan, A. Hesseling-Meinders, S. P. Voravuthikunchai, J. M. van Dijl, and O. Kayser, “Potential antibiotic and anti-infective effects of rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. on Streptococcus pyogenes as revealed by proteomics,” Phytomedicine, vol. 18, no. 11, pp. 934–940, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Sianglum, P. Srimanote, W. Wonglumsom, K. Kittiniyom, and S. P. Voravuthikunchai, “Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate,” PLoS ONE, vol. 6, no. 2, Article ID e16628, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Visutthi, P. Srimanote, and S. P. Voravuthikunchai, “Responses in the expression of extracellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone,” The Journal of Microbiology, vol. 49, no. 6, pp. 956–964, 2011. View at Google Scholar